相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation
Toshihiro Miyamoto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
Grazia Locafaro et al.
MOLECULAR THERAPY (2017)
Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
Arjang Baygan et al.
FRONTIERS IN IMMUNOLOGY (2017)
Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination
Neeraj Saini et al.
ANNALS OF HEMATOLOGY (2017)
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study
Manuel Jurado et al.
CYTOTHERAPY (2017)
Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
Neil Dunavin et al.
BIOMEDICINES (2017)
Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients
Pooja Khandelwal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention
F. Khimani et al.
BONE MARROW TRANSPLANTATION (2017)
Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation
G. M. Dotoli et al.
BONE MARROW TRANSPLANTATION (2017)
Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells
Elodie Picarda et al.
JCI INSIGHT (2017)
Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study
Kazuo Muroi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Cellular and molecular mechanisms in graft-versus-host disease
Lingling Zhang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-versus-Host Disease and Retains Graft-versus-Leukemia Activity
Shuting Zhao et al.
ACS NANO (2016)
Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease
Lenneke F. J. van Groningen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells
Mathieu Leclerc et al.
BLOOD (2016)
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
M. Mielcarek et al.
BLOOD (2016)
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
Ryan Flynn et al.
BLOOD (2016)
Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses
Yusuke Shono et al.
CANCER RESEARCH (2016)
Ruxolitinib in steroid refractory graft-vs.host disease: a case report
Enrico Maffini et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update
W. Arcese et al.
BONE MARROW TRANSPLANTATION (2015)
Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models
Dan Yang et al.
CELL TRANSPLANTATION (2015)
Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy
Mustapha Cherai et al.
CELL TRANSPLANTATION (2015)
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R. Zeiser et al.
LEUKEMIA (2015)
Imatinib for sclerodermatous graft-versus-host disease in lung transplantation
Jitian Zhang et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2015)
Clinical Outlook for Type-1 and FOXP3+ T Regulatory Cell-Based Therapy
Silvia Gregori et al.
FRONTIERS IN IMMUNOLOGY (2015)
Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD
Anne-Kathrin Hechinger et al.
BLOOD (2015)
A multicentre UK study of GVHD following DLI: Rates of GVHD are high but mortality from GVHD is infrequent
J. J. Scarisbrick et al.
BONE MARROW TRANSPLANTATION (2015)
Administration of Anti-CD20 mAb Is Highly Effective in Preventing but Ineffective in Treating Chronic Graft-Versus-Host Disease While Preserving Strong Graft-Versus-Leukemia Effects
Heather F. Johnston et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients
Martino Introna et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
Erin Gatza et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
Massimo F. Martelli et al.
BLOOD (2014)
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
Silvia Spoerl et al.
BLOOD (2014)
Mesenchymal stem cells suppress CD8+ T cell-mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3-dioxygenase and transforming growth factor-β
Mingfen Li et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
Alana A. Kennedy-Nasser et al.
CLINICAL CANCER RESEARCH (2014)
Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols
Chiara Capelli et al.
HAEMATOLOGICA (2014)
PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation
Sung-Hee Lee et al.
IMMUNOLOGY LETTERS (2014)
Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease
Doanh Le Huu et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease
Muriel Hannon et al.
TRANSFUSION (2014)
A Small-Molecule c-Rel Inhibitor Reduces Alloactivation of T Cells without Compromising Antitumor Activity
Yusuke Shono et al.
CANCER DISCOVERY (2014)
Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
Joo Han Park et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice
Nayoun Kim et al.
ANNALS OF HEMATOLOGY (2013)
Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells
Piotr Trzonkowski et al.
BIODRUGS (2013)
CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease
James M. Coghill et al.
BLOOD (2013)
Anionic carbohydrate-containing chitosan scaffolds for bone regeneration
Hyejin Park et al.
CARBOHYDRATE POLYMERS (2013)
Promoting transplantation tolerance; adoptive regulatory T cell therapy
N. Safinia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Human mesenchymal stem cells suppress donor CD4+T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease
L. M. Tobin et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Risk of tumorigenicity in mesenchymal stromal cell-based therapies-Bridging scientific observations and regulatory viewpoints
Lisbeth Barkholt et al.
CYTOTHERAPY (2013)
Immunomodulation with donor regulatory T cells armed with Fas-ligand alleviates graft-versus-host disease
Esma S. Yolcu et al.
EXPERIMENTAL HEMATOLOGY (2013)
Advances in the treatment of acute graft-versus-host disease
Liren Qian et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Blockade of individual Notch ligands and receptors controls graft-versus-host disease
Ivy T. Tran et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
T Cell-Specific Notch Inhibition Blocks Graft-versus-Host Disease by Inducing a Hyporesponsive Program in Alloreactive CD4+ and CD8+ T Cells
Ashley R. Sandy et al.
JOURNAL OF IMMUNOLOGY (2013)
Cutting Edge: Receptors for C3a and C5a Modulate Stability of Alloantigen-Reactive Induced Regulatory T Cells
William van der Touw et al.
JOURNAL OF IMMUNOLOGY (2013)
Third-party Tolerogenic Dendritic Cells Reduce Allo-reactivity In vitro and Ameliorate the Severity of Acute graft-Versus-host Disease in Allo-bone Marrow Transplantation
J. Yang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
Human CD8+ Regulatory T Cells Inhibit GVHD and Preserve General Immunity in Humanized Mice
Jian Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Targeting CD83 for the treatment of graft-versus-host disease (Review)
Xiongfei Wang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro
Cristina Nazarov et al.
STEM CELL RESEARCH & THERAPY (2013)
Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL
Michael R. Verneris
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab' Antibody
N. Poirier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Prophylactic Effects of Interleukin-2 Receptor Antagonists against Graft-versus-Host Disease Following Unrelated Donor Peripheral Blood Stem Cell Transplantation
Jun Fang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes
Sung W. Choi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
Paul J. Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17
Hisakazu Nishimori et al.
BLOOD (2012)
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Manoj M. Lalu et al.
PLOS ONE (2012)
Long-term follow-up of children treated with daclizumab for steroid-refractory gastrointestinal GvHD in a prospective study
Amir Ali Hamidieh et al.
PEDIATRIC TRANSPLANTATION (2012)
Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
Jun Yang et al.
PEDIATRIC TRANSPLANTATION (2012)
Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
Aurelie Moreau et al.
FRONTIERS IN IMMUNOLOGY (2012)
Advances in graft-versus-host disease biology and therapy
Bruce R. Blazar et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Cell Therapy With Autologous Tolerogenic Dendritic Cells Induces Allograft Tolerance Through Interferon-Gamma and Epstein-Barr Virus-Induced Gene 3
M. Hill et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Pharmacologic Expansion of Donor-Derived, Naturally Occurring CD4+ Foxp3+ Regulatory T Cells Reduces Acute Graft-versus-Host Disease Lethality Without Abrogating the Graft-versus-Leukemia Effect in Murine Models
Omar Duramad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
Ho-Jin Shin et al.
BLOOD (2011)
Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD
A. Rager et al.
BONE MARROW TRANSPLANTATION (2011)
The use of monoclonal antibodies for the treatment of graft-versus-host disease following allogeneic stem cell transplantation
Alessandro Busca
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?
Nathalie Cools et al.
IMMUNOTHERAPY (2011)
Negative vaccination by tolerogenic dendritic cells in organ transplantation
Marcelo Hill et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2010)
Development of Dendritic Cell-Based Immunotherapy for Autoimmunity
Catharien M. U. Hilkens et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2010)
Induction of Kidney Allograft Tolerance by Soluble CD83 Associated With Prevalence of Tolerogenic Dendritic Cells and Indoleamine 2,3-Dioxygenase
Zhu Lan et al.
TRANSPLANTATION (2010)
Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection
Wei Ge et al.
TRANSPLANTATION (2010)
A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease
Daniel R. Couriel et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis
Mohamed A. Kharfan-Dabaja et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience
M. Miano et al.
BONE MARROW TRANSPLANTATION (2009)
Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
John Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Improved Survival and Preserved Antiviral Responses After Combination Therapy With Daclizumab and Infliximab in Steroid-refractory Graft-Versus-Host Disease
Kanchan Rao et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Dendritic cell CD83: A therapeutic target or innocent bystander?
Charlene M. Prazma et al.
IMMUNOLOGY LETTERS (2008)
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans
Maria-Grazia Roncarolo et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
Alessandro Busca et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease
Jose Luis Pinana et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Rituximab for steroid-refractory chronic graft-versus-host disease
Corey Cutler et al.
BLOOD (2006)
Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-verus-host-disease by inhibiting activation/differentiation of pathogenic T cells
A Trenado et al.
JOURNAL OF IMMUNOLOGY (2006)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
分享论文
